Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Tessa Therapeutics
Singapore
C
101-250 Employees
2001
Key takeaway
Tessa Therapeutics is focused on developing innovative cell therapies for cancer, including their unique allogeneic CD30-CAR EBVST platform, which targets a wide range of cancers. This approach represents a significant advancement in the field of CAR-T cell therapy.
Reference
Product
Technology | Tessa Therapeutics – Cancer Immunotherapy Treatments
A comprehensive approach to cancer immunotherapy. Successful cancer immunotherapy treatments mimic core aspects of the body’s anti-viral immune response.
CellVec Pte Ltd
Singapore
C
11-50 Employees
2018
Key takeaway
CellVec is a certified GMP gene therapy CDMO that specializes in providing custom viral vectors for pre-clinical and clinical applications. Their advanced lentivirus-based CellVec Vector Platform addresses production challenges, facilitating the development of innovative gene transfer technologies for therapies like CAR-T cell therapy.
Reference
Core business
CellVec | Innovation for Patient Benefit
A certified GMP gene therapy CDMO that is a specialist provider of custom viral vectors for pre-clinical and clinical applications
Advanced Cell Therapy and Research Institute Singapore
Singapore
C
51-100 Employees
2020
Key takeaway
ACTRIS is dedicated to advancing cellular-based therapeutics, including CAR-T cell therapy, by focusing on discovery, process development, and manufacturing. Their goal is to achieve regulatory accreditation to ensure quality compliance in the production of these innovative therapies.
Reference
Service
Our Services | Cell Therapy Manufacturing and Process Development
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Guardant Health AMEA
Singapore
C
11-50 Employees
2018
Key takeaway
Guardant Health AMEA is focused on advancing cancer treatment through innovative solutions, including blood tests that provide critical molecular information. Their collaboration with pharmaceutical companies aims to discover new therapeutic approaches, ultimately improving outcomes for patients with advanced cancer.
Reference
Core business
Guiding Cancer Treatment | Liquid Biopsy - Guardant360
Guardant Health AMEA is dedicated to helping cancer patients get the right treatment. Contact us to learn more about the new cancer treatment in Singapore.
Clearbridge Medical Group
Singapore
C
11-50 Employees
-
Key takeaway
The company emphasizes its commitment to efficient solutions for early disease detection and personalized chronic disease management, which may relate to the advancements in therapies like CAR-T cell therapy.
Reference
Product
CellSearch CTC Brochure | Clearbridge Medical Group
CellSearch CTC Brochure
Cellivate Technologies
Singapore
C
1-10 Employees
2019
Key takeaway
Cellivate focuses on providing cell-based solutions, highlighting their work with sustainable cell technologies. Their expertise in cell growth products and technologies may be relevant to advancements in therapies like CAR-T cell therapy.
Reference
Product
Products — Cellivate Technologies
Terumo Asia Pacific
Singapore
C
251-500 Employees
-
Key takeaway
Terumo Cardiovascular develops and distributes medical devices, including those related to cell therapy technology. Their extensive portfolio emphasizes innovative solutions that enhance patient outcomes in various clinical settings.
Reference
Core business
Terumo
Taiho Pharma Asia Pacific Pte. Ltd.
Singapore
C
11-50 Employees
2011
Key takeaway
Taiho Pharma Asia Pacific is dedicated to enhancing the lives of cancer patients by introducing high-quality anticancer drugs and focusing on innovative therapies. Their commitment to the well-being of patients highlights their role in advancing cancer care in the region.
Reference
Product
Products - TAIHO PHARMA ASIA PACIFIC
TAIHO PHARMA ASIA PACIFIC focus as we pioneer and produce our line of specialty pharmaceuticals is not the drug industry, but the benefit of the people we serve.
MiRXES
Singapore
C
11-50 Employees
2014
Key takeaway
MiRXES is a biotechnology company focused on early disease detection through innovative RNA technology, developing non-invasive blood tests for cancer. Their commitment to accessible diagnostic solutions aligns with advancements in personalized medicine and early intervention strategies.
Reference
Core business
Homepage - MiRXES
A NEW DAWN in disease early interception Featured Our Science & Pipeline At MiRXES, we harness the power of RNA to deliver early, actionable and personalized diagnoses across the care continuum to improve and save lives. Prevention is better than cure. With early detection, mitigating risk factors and implementing prevention strategies, most cancer deaths can … Homepage Read More »
BioConnexUS
Singapore
C
1-10 Employees
2017
Key takeaway
The company focuses on developing market entry and localization strategies, which could be relevant for the introduction of CAR-T cell therapy in the US through engagement with key opinion leaders and hospital systems for clinical trials.
Reference
Core business
Bioconnex US
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T Cell Therapy industry in Singapore, several key considerations are essential. The regulatory landscape is one of the most critical factors, as the Health Sciences Authority (HSA) oversees the approval and monitoring of advanced therapies. Understanding the intricacies of clinical trial protocols and regulatory compliance is vital for any company operating in this space. Challenges include the high costs associated with CAR-T therapies and the complexities of manufacturing personalized treatments. However, the sector presents significant opportunities, particularly due to Singapore's position as a regional hub for biopharmaceutical development and research. The local government actively supports innovation through funding and infrastructure development, making it an attractive environment for investment and collaboration. Environmental concerns also play a role, as sustainable practices in manufacturing and waste management are increasingly scrutinized. The competitive landscape features established pharmaceutical companies alongside emerging biotech firms, creating a dynamic ecosystem. Additionally, global market relevance cannot be overlooked, as advancements in CAR-T therapies are rapidly evolving, and Singapore is strategically positioned to contribute to this growth on an international scale. Overall, a thorough understanding of these aspects will provide valuable insights for anyone interested in the CAR-T Cell Therapy industry in Singapore.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Singapore |
| Amount of fitting manufacturers | 54 |
| Amount of suitable service providers | 47 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2001 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are IT, Software and Services, Finance and Insurance, Biotechnology, Healthcare, Other
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.